Sort
326,823 grants matching “clinical trial”
Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease
$2,846,103Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Understanding Papillomavirus Virion Proteins and Vaccines
$2,845,656John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Indiana University Melvin and Bren Simon Comprehensive Cancer Center Support Grant
$2,845,630Kelvin P Lee · Indiana University Indianapolis · P30 · FY2024 · CA
University of Illinois at Chicago Hemodialysis Opioid Prescription Effort (HOPE) Clinical Center
$2,845,360Michael J. Fischer · University Of Illinois At Chicago · U01 · FY2019 · DK
Data Management and Coordinating Center (DMCC)
$2,845,000Jeffrey P Krischer · University Of South Florida · U54 · FY2009 · NS
Data Management and Coordinating Center (DMCC)
$2,845,000Jeffrey P Krischer · University Of South Florida · U54 · FY2009 · NS
A prospective registry, biobank and observational study of food allergy
$2,844,883Corinne Keet · Johns Hopkins University · UM2 · FY2021 · AI
A Phase 3 Pivotal Trial of AGB101 to Slow Progression in MCI due to Alzheimer's Disease
$2,844,834Richard C. Mohs · Agenebio, Inc. · R01 · FY2021 · AG
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$2,844,792David S Stephens · Emory University · UM1 · FY2020 · AI
HYPERTHERMIA AND PERFUSION EFFECTS IN CANCER THERAPY
$2,844,487Duke University · P01 · FY2002 · CA
Data Coordinating Center for Organ Transplant Clinical *
$2,844,133Jun Liu · Ppd Development Lp · U01 · FY2009 · AI
Data Management and Reporting Group
$2,843,578Lasonia Morgan · Rho Federal Systems Division, Inc. · UM2 · FY2020 · AI
Targeted Clincial Trials to Reduce the Risk of Antimocribal Resistance
$2,842,831Keith Kaye · Wayne State University · N01 · FY2010 · AI
Medical Oncology Service Clinical Core
$2,842,329Arun Rajan · Division Of Basic Sciences - Nci · ZID · FY2023 · CA
Diabetes and Periodontics Trial - Administrative Center/Study Chair
$2,842,256Steven P Engebretson · State University New York Stony Brook · U01 · FY2011 · DE
Genetic regulation of epithlial injury in ulcerative colitis
$2,842,245Michael George Kattah · Mayo Clinic Rochester · R01 · FY2025 · DK
Moffitt Cancer Center Support Grant
$2,842,201Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2014 · CA
Specialized Programs of Translational Research in Acute Stroke at the Partners
$2,842,125Steven M Greenberg · Massachusetts General Hospital · P50 · FY2012 · NS
ARMADA: Advancing Reliable Measurement in Alzheimer's Disease and cognitive Aging
$2,841,869Richard Gershon · Northwestern University At Chicago · U2C · FY2018 · AG
Aging, Cognition, and Hearing Evaluation in Elders (ACHIEVE) Randomized Trial
$2,841,558Frank R Lin · Johns Hopkins University · R01 · FY2020 · AG
Randomized Control Trial of oxygen therapy in Children and Adolescents with Down Syndrome and Obstructive Sleep Apnea
$2,841,336Raouf S Amin · Cincinnati Childrens Hosp Med Ctr · R61 · FY2022 · HL
Core D - Genomics
$2,841,208Alexander L Greninger · Emory University · U19 · FY2022 · AI
Targeting Cellular Senescence to Extend Healthspan
$2,841,000Sundeep Khosla · Mayo Clinic Rochester · P01 · FY2021 · AG
Metro-Minnesota Community Clinical Oncology Program (MM-CCOP)
$2,840,966Daniel M Anderson · Healthpartners Institute · UG1 · FY2018 · CA
Development of a treatment for secretory diarrhea
$2,840,747Active Pass Pharmaceuticals, Inc. · UC1 · FY2004 · AI